For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Quick Order bolt
Request Quote sms
Applications
Gabapentin extracted from plasma (25 µg/mL) using PPT on a Kinetex C18 2.6µm, 50x2.1mm
19689
Separation Mode: Reversed Phase
Reversed Phase
C18
HPLC
Antiparkinson Agents
Clinical

Gabapentin extracted from plasma (25 µg/mL) using PPT on a Kinetex C18 2.6µm, 50x2.1mm

zoom_in
Analytes
1Gabapentin-d4
2Gabapentin
Details
LC Conditions (App ID: 19689)
Column:
Brand Name:
Kinetex
Part No:
Phase Name:
C18
Similar Applications
search
No Data
Phenomenex
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide
Danaher
Connect With Us
Phenomenex
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide

Products and Services

Products

Techniques

Industries

Quick Order

Support

Product Method Support

Product Troubleshooting

Contact Us

CQA CofA

Our company

About Phenomenex

Blog

News

Danaher Life Sciences

Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Impressum
© 2024  Phenomenex Inc. All rights reserved.